Immunogenicity of SARS-CoV-2 vaccination in patients undergoing autologous stem cell transplantation. A multicentric experience.

Front Oncol · 2022 · PMC9755510 · PMID 36531008

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

When considering time, we found out that the distance between aHSCT and vaccine did not increase seropositivity (OR 1.18, CI 1.02–1.41, p-value of 0.04), particularly after 12 months, even if this partition of time (≤6 months, between 7 and 12 months, and > 12 months) did not reach statistical significance for any disease (OR 6, CI 0.86–122, p-value of 0.12).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.